I would like to add that NIH has extended the Eltrombopag clinical trials to MDS patients as well due to the success of the trial with their AA patients.
Anyone interested should read my posts regarding Promacta (Eltrombopag) and the almost miraculous success my husband has had with this drug.
After over 125 red/platelet transfusions, he has been transfusion independent for going on 3 years now after taking Promacta. He stopped taking Promacta when his platelet count reached 100,000. His platelets are still over 100,000, his RBC and WBC have remained normal. All three of his blood lines were affected. He is currently taking no medication for his MDS and is doing so well we tend to forget he has MDS.
If any questions please feel free to contact me -
shcalvert3@aol.com.
God Bless,
Sally